Atlantic Healthcare Plc

Atlantic Healthcare is a specialist pharma company, focused on developing and commercializing gastrointestinal therapeutics to address unmet patient needs

Atlantic Healthcare is an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal disorders including Inflammatory Bowel Disease (IBD). The Group's lead product is alicaforsen enema, in a pivotal Phase 3 trial for pouchitis, and in preparation for a pivotal Phase 3 clinical trial in ulcerative colitis (UC).

Alicaforsen enema has the potential to establish a new class of therapy for the treatment of IBD, with clear differentiating features.

Alicaforsen enema is currently in a Phase 3 trial agreed with U. S. , Canadian and European regulatory agencies in patients with active, chronic pouchitis. The trial is recruiting patients across the U. S. , Canada and Europe.